Group 1 - The company reported a robust revenue growth of 17.29% year-on-year, achieving an operating income of 4.108 billion yuan in H1 2025 [1] - The net profit attributable to the parent company reached 524 million yuan, reflecting a significant increase of 30.65% year-on-year [1] - The gross margin for H1 2025 was 75.52%, a slight decrease of 0.99 percentage points, while the net profit margin improved by 1.74 percentage points to 13.52% [1] Group 2 - The main brand, Han Shu, generated revenue of 3.344 billion yuan in H1 2025, marking a 14.3% increase, with significant sales from the Hong Man Yao and X Peptide series [2] - The second brand, Newpage, saw a remarkable revenue growth of 146.5% year-on-year, reaching 397 million yuan, achieving its annual sales target for 2024 [2] - The company is actively enhancing its online sales strategy, with self-operated online channels generating 3.421 billion yuan in revenue, a 24.6% increase, and accounting for 83.3% of total revenue [2] Group 3 - The company is expected to achieve net profits of 1.025 billion yuan, 1.286 billion yuan, and 1.566 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding PE ratios of 32, 26, and 21 [3]

Industry Overview - The beauty industry is witnessing significant developments, including financial reports from various companies and the successful registration of new raw materials like Ursolic Acid [1] - Major brands are launching new products and entering new markets, indicating a dynamic and evolving landscape [1] Company Performance - Up Beauty reported a record revenue of 4.108 billion yuan for the first half of 2025, a year-on-year increase of 17.3%, with a net profit of 556 million yuan, up 34.7% [2] - Giant Biological achieved a revenue of 3.113 billion yuan in the first half of 2025, reflecting a 22.5% year-on-year growth, with a net profit of 1.182 billion yuan, up 20.6% [21] - Huaxi Biological reported a revenue of 2.261 billion yuan, with net profit figures showing no growth, but signs of strategic adjustments beginning to take effect [22] - Marubi Biological's revenue for the first half of 2025 reached 1.769 billion yuan, a 30.83% increase year-on-year, with a net profit of 186 million yuan, up 5.21% [23] New Product Developments - Up Beauty is preparing to launch a new makeup brand called "Dan Cai" in collaboration with a renowned makeup artist [2] - COSMAX announced breakthroughs in anti-aging and whitening products, including a new NAD-based anti-aging cosmetic and a new whitening powder [3] - LV Cosmetics has begun global pre-sales, indicating a strong push into the market [15] Executive Changes - Proya appointed new executives, including Xue Xia as the board secretary and Guo Xiao as the Chief Marketing Officer, both bringing extensive experience in the consumer sector [4] - Givaudan announced a leadership change, with Gilles Andrier stepping down as CEO in March 2026, to be succeeded by Christian Stammkoetter [5] Market Trends - The beauty and skincare market saw sales of 235.23 billion yuan in the first half of 2025, a 10.1% year-on-year increase, with anti-aging products showing a significant growth of 30.3% [24] - The introduction of innovative products and strategic partnerships, such as COSMAX's collaboration with Korea University for climate-proof cosmetics, reflects the industry's adaptability to changing consumer needs [15]

Core Viewpoint - The company reported strong performance for H1 2025, with revenue of 4.11 billion yuan, a year-on-year increase of 17.3%, and a net profit of 560 million yuan, up 34.7% year-on-year, falling within the upper range of previous forecasts [1][2]. Revenue Breakdown - The multi-brand matrix continues to grow, with online revenue increasing by 20.1% year-on-year in H1 2025. By brand, revenue for 韩束, Newpage 一页, 红色小象, 一叶子, and other brands were 3.34 billion, 400 million, 160 million, 90 million, and 120 million yuan respectively, with year-on-year changes of +14.3%, +146.5%, -8.7%, -29.0%, and +2.9% [1]. - By channel, online and offline revenues were 3.81 billion and 270 million yuan respectively, with year-on-year changes of +20.1% and -10.6% [1]. - By segment, skincare, maternal and infant care, and other categories generated revenues of 3.42 billion, 560 million, and 130 million yuan respectively, with year-on-year changes of +10.2%, +65.0%, and +124.3% [1]. Profitability Metrics - The net profit margin increased by 1.7 percentage points year-on-year to 13.5%. The gross margin for H1 2025 was 75.5%, down 1 percentage point year-on-year, while the expense ratio was 63.2%, up 0.03 percentage points [2]. Brand Performance - The main brand 韩束 showed steady growth, maintaining the top position in beauty brands on Douyin, with GMV growth of +15.5% on Douyin and +26.1% on Tmall. Star products like 红蛮腰 sold over 15 million units, and the X 肽 series generated over 200 million yuan in sales [2]. - The Newpage 一页 brand rapidly expanded, targeting skincare products for ages 0-18, with significant sales during the 618 shopping festival, achieving GMV growth of +190% on Douyin and +106% on Tmall [2]. Brand Portfolio Expansion - The company has a robust pipeline of brands across multiple segments, including a sensitive skin care brand in collaboration with 昆药集团, a high-end skincare brand 聚光白, and a high-end anti-aging brand TAZU. Additionally, it is preparing to launch IP co-branded products in maternal and infant care and new hair care and makeup brands [3]. Profit Forecast and Investment Rating - The company is expected to achieve net profits of 1.11 billion, 1.41 billion, and 1.76 billion yuan for 2025-2027, representing year-on-year growth of 42.3%, 26.5%, and 24.8% respectively. The latest closing price corresponds to PE ratios of 30, 24, and 19 times for the respective years, maintaining a "buy" rating [3].

Core Viewpoint - The company reported strong revenue and profit growth for the first half of 2025, with a 17.3% increase in revenue and a 30.6% increase in net profit attributable to shareholders, indicating robust operational performance and market positioning [1][2]. Financial Performance - The company achieved a revenue of 4.11 billion RMB and a net profit of 520 million RMB in the first half of 2025, with an EPS of 1.32 RMB [1]. - The gross margin decreased by 1 percentage point to 75.5%, while the expense ratio remained stable at 63.2% [2]. - Inventory increased by 7.2% year-on-year to 680 million RMB, with inventory turnover days decreasing by 5 days to 249 days [2]. - Operating net cash flow grew significantly by 77.5% to 390 million RMB [2]. Brand and Product Development - The main brand, Han Shu, maintained its leading position on the Douyin platform, ranking first among beauty brands and expanding its product line with new offerings [3]. - The company is actively pursuing a multi-brand strategy, launching new brands in various categories, including skincare, maternal and infant care, and cosmetics [3]. - New brands such as An Min You for sensitive skin and a high-end anti-aging brand TAZU are in development, alongside collaborations with well-known IPs for maternal and infant products [3]. Market Strategy and Outlook - The company is expected to benefit from its multi-brand strategy, which is anticipated to inject new growth momentum and enhance operational efficiency and profit margins [4]. - Profit forecasts for 2025, 2026, and 2027 have been adjusted upward to 1.16 billion RMB, 1.47 billion RMB, and 1.83 billion RMB, respectively, reflecting confidence in the company's growth trajectory [4].